相关实验视频

Updated: Sep 12, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

坦辛I-皮里迪尼盐衍生物的合成和生物活性研究

Huimin Zhao¹, Yuyang Wang¹, Zining Liu¹

¹Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; School of Pharmacy, Yunnan University, Kunming, 650500, People's Republic of China.

Natural products and bioprospecting

|August 8, 2025

概括

新的tanshinone I-pyridinium盐衍生物被合成以改善抗癌性质. 化合物a4表现出强大的细胞毒性和向PI3Kα,为癌症治疗开发提供了一个有前途的新途径.

科学领域:

药用化学医学化学
药理学药理学是指药理学的学科.
在瘤学瘤学.

背景情况:

天然产品Tanshinone I的临床应用受限,原因是功效较弱,药物特性较差.
新型抗癌药物的开发对于有效的癌症治疗至关重要.

研究的目的:

设计和合成具有增强抗瘤活性的新型tanshinone I-pyridinium盐衍生物.
评估这些衍生物的细胞毒性和初步作用机制.

主要方法:

合成了20种tanshinone I-pyridinium盐衍生物和一个前体.
在体外细胞毒性测定对乳腺,肝脏和前列腺癌细胞系.
包括PI3Kα抑制和PI3K/Akt/mTOR通路蛋白和PD-L1表达的西方抹杀在内的初步机制研究.

主要成果:

化合物a4对MDA-MB-231,HepG2和22RV1细胞系表现出强烈的细胞毒性 (IC50: 1.40-1.63μM).
a4针对PI3Kα (IC50:9.24±0.20μM) 并抑制PI3K/Akt/mTOR信号传递.
a4显著降低PD-L1表达的调节,表明潜在的免疫激活.

结论:

坦辛I-皮里迪尼盐衍生物a4是一种强大的新型PI3Kα抑制剂,具有显著的抗瘤活性.
a4通过向PI3Kα和调节免疫检查点蛋白来证明癌症治疗的潜力.
这项研究为进一步开发a4作为抗癌剂提供了坚实的基础.

关键词:

它具有抗瘤活性.皮里迪尼盐的盐类结构修改是指结构的修改.结构活动关系结构活动关系坦西诺尼我一个人.

更多相关视频

Synthesis of pH Dependent Pyrazole, Imidazole, and Isoindolone Dipyrrinone Fluorophores using a Claisen-Schmidt Condensation Approach

Synthesis of pH Dependent Pyrazole, Imidazole, and Isoindolone Dipyrrinone Fluorophores using a Claisen-Schmidt Condensation Approach

Published on: June 10, 2021

Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities

Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities

Published on: October 2, 2018

相关概念视频

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...